Fibrocell Science: A Very Appealing Gene Therapy Play – Seeking Alpha
Seeking Alpha |
Fibrocell Science: A Very Appealing Gene Therapy Play
Seeking Alpha Shares may have risen by over 50% year to date, but they are still in the red by almost 70% over the past three years. Interim results from a phase 1/2 clinical trial of drug candidate FCX-007 were very encouraging. A comparison to gene therapy … |
